According to new spinal implant reports by iData Research (www.idataresearch.net), the leading global authority in medical device and pharmaceutical market research, the U.S. market for spinal implants is estimated to exceed $8 billion by 2016, while the MIS spinal implant market is estimated to reach over $3 Billion. In addition, rapid growth in artificial disc use will fuel the spinal motion preservation market to increase six-fold by 2016.
While many have predicted the cannibalization of spinal fusion procedures by motion preservation, iData’s report reveals healthy growth in the fusion market driven by a consistent rise in minimally invasive surgical (MIS) interbody procedures, the market for which will triple by 2016.
“Lateral lumbar interbody fusion, such as NuVasive’s XLIF(R) (NASDAQ:NUVA), is the most rapidly increasing MIS interbody fusion procedure,” says Dr. Kamran Zamanian, CEO of iData.
Despite growth in spinal fusion, the competing spinal motion preservation market, which includes cervical artificial discs, is also expected to experience strong growth. Reimbursement policies for motion preservation devices are expected to continue to drive this market.
“The cervical artificial disc segment is aiding strong growth in the spinal motion preservation market,” says Dr. Zamanian. “Companies such as DePuy, Medtronic and Synthes are leading the market, while many competitors such as Cervitech, Globus, NuVasive, SpinalMotion, and Zimmer are expected to emerge into this segment in the next few years.”
iData’s global report series on the “Markets for Spinal Implants & VCF 2010” and the “Markets for Minimally Invasive Spinal Devices 2010” also covers VCF, spinous process fixation, facet fixation and MIS pedicle screws.
For more information, register free on iData’s website at:http://www.idataresearch.net/idata/registration.php
About iData Research
iData Research (www.idataresearch.net/idata/discoveridata.php) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies.